Literature DB >> 7143372

Potential radiosensitizing agents. 5. 2-Substituted benzimidazole derivatives.

R P Gupta, C A Larroquette, K C Agrawal.   

Abstract

A series of 2-substituted benzimidazoles and their derivatives have been synthesized and tested for their ability to selectively sensitize hypoxic Chinese hamster cells (V-79) toward the lethal effect of ionizing radiation. These compounds were prepared by reacting the 2-substituted benzimidazoles with 1,2-epoxy-3-methoxypropane in the presence of potassium carbonate. Reaction of the 2-nitro and 2-methylfonyl analogue with the epoxide also yielded a cyclized material, which was confirmed to be a benzimidazo[2,1-b]oxazole. In an attempt to increase the electron affinity, 5- or 6-nitro-2-substituted-benzimidazoles were also synthesized and then reacted with the epoxide to yield the corresponding 1-substituted derivatives. The results of the biological tests for the radiosensitizing activity of these agents against Chinese hamster cells (V-79) in culture indicated that the 2-nitro-substituted analogues were the most effective sensitizers in this series.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143372     DOI: 10.1021/jm00353a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies.

Authors:  Qiwen Duan; Yanfeng Liu; Carmen J Booth; Sara Rockwell
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

2.  Fenbendazole as a potential anticancer drug.

Authors:  Qiwen Duan; Yanfeng Liu; Sara Rockwell
Journal:  Anticancer Res       Date:  2013-02       Impact factor: 2.480

3.  Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells.

Authors:  Zuzana Mrkvová; Stjepan Uldrijan; Antonio Pombinho; Petr Bartůněk; Iva Slaninová
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.